Gilder Gagnon Howe & CO LLC Bio N Tech Se Transaction History
Gilder Gagnon Howe & CO LLC
- $7.02 Billion
- Q1 2025
A detailed history of Gilder Gagnon Howe & CO LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 649,284 shares of BNTX stock, worth $72.6 Million. This represents 0.84% of its overall portfolio holdings.
Number of Shares
649,284
Previous 281,412
130.72%
Holding current value
$72.6 Million
Previous $32.1 Million
84.38%
% of portfolio
0.84%
Previous 0.37%
Shares
16 transactions
Others Institutions Holding BNTX
# of Institutions
341Shares Held
40MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$912 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$476 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$452 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$212 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$202 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.1B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...